| scholarly article | Q13442814 |
| P50 | author | Antonieta Guerrero-Plata | Q61114173 |
| P2093 | author name string | Carolyn M Clark | |
| P2860 | cites work | Recovery of cytopathogenic agent from chimpanzees with coryza | Q74223084 |
| Structure of RSV Fusion Glycoprotein Trimer Bound to a Prefusion-Specific Neutralizing Antibody | Q27677570 | ||
| Synthetic Biodegradable Microparticle and Nanoparticle Vaccines against the Respiratory Syncytial Virus | Q28067143 | ||
| Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis | Q29619821 | ||
| Characterization of two antigenic sites recognized by neutralizing monoclonal antibodies directed against the fusion glycoprotein of human respiratory syncytial virus | Q30334543 | ||
| Immunogenicity and safety of a respiratory syncytial virus fusion protein (RSV F) nanoparticle vaccine in older adults | Q33555911 | ||
| Respiratory syncytial virus and parainfluenza virus | Q33952428 | ||
| Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine | Q34206177 | ||
| A live RSV vaccine with engineered thermostability is immunogenic in cotton rats despite high attenuation | Q34547769 | ||
| The burden of respiratory syncytial virus infection in young children | Q34938343 | ||
| Neutralizing antibodies against the preactive form of respiratory syncytial virus fusion protein offer unique possibilities for clinical intervention | Q35778982 | ||
| Clinical Presentation and Birth Outcomes Associated with Respiratory Syncytial Virus Infection in Pregnancy | Q35975363 | ||
| Universal vaccine against respiratory syncytial virus A and B subtypes | Q36338294 | ||
| Mucosal vaccines: the promise and the challenge | Q36402244 | ||
| Novel Respiratory Syncytial Virus-Like Particle Vaccine Composed of the Postfusion and Prefusion Conformations of the F Glycoprotein. | Q36973952 | ||
| Genetic stability of genome-scale deoptimized RNA virus vaccine candidates under selective pressure | Q37599051 | ||
| Preclinical evaluation of bacterially produced RSV-G protein vaccine: Strong protection against RSV challenge in cotton rat model | Q37635077 | ||
| The burgeoning burden of respiratory syncytial virus among children | Q37984107 | ||
| A Single-Dose Recombinant Parainfluenza Virus 5-Vectored Vaccine Expressing Respiratory Syncytial Virus (RSV) F or G Protein Protected Cotton Rats and African Green Monkeys from RSV Challenge | Q38905050 | ||
| Antigenic structure of human respiratory syncytial virus fusion glycoprotein. | Q39579940 | ||
| Induction of high titred, non-neutralising antibodies by self-adjuvanting peptide epitopes derived from the respiratory syncytial virus fusion protein. | Q40046506 | ||
| Virus-like particle vaccine primes immune responses preventing inactivated-virus vaccine-enhanced disease against respiratory syncytial virus | Q40067942 | ||
| Attenuated Human Parainfluenza Virus Type 1 Expressing the Respiratory Syncytial Virus (RSV) Fusion (F) Glycoprotein from an Added Gene: Effects of Prefusion Stabilization and Packaging of RSV F | Q40072947 | ||
| Intranasal immunization with a single dose of the fusion protein formulated with a combination adjuvant induces long-term protective immunity against respiratory syncytial virus | Q40076730 | ||
| Parainfluenza Virus 5 Expressing Wild-Type or Prefusion Respiratory Syncytial Virus (RSV) Fusion Protein Protects Mice and Cotton Rats from RSV Challenge | Q40107059 | ||
| The importance of RSV F protein conformation in VLPs in stimulation of neutralizing antibody titers in mice previously infected with RSV. | Q40163890 | ||
| Improved Prefusion Stability, Optimized Codon Usage, and Augmented Virion Packaging Enhance the Immunogenicity of Respiratory Syncytial Virus Fusion Protein in a Vectored-Vaccine Candidate. | Q40187606 | ||
| A single intranasal administration of virus-like particle vaccine induces an efficient protection for mice against human respiratory syncytial virus | Q40191738 | ||
| Mutating the CX3C Motif in the G Protein Should Make a Live Respiratory Syncytial Virus Vaccine Safer and More Effective | Q40301155 | ||
| A Respiratory Syncytial Virus Vaccine Vectored by a Stable Chimeric and Replication-Deficient Sendai Virus Protects Mice without Inducing Enhanced Disease. | Q40312271 | ||
| Immunization with Low Doses of Recombinant Postfusion or Prefusion Respiratory Syncytial Virus F Primes for Vaccine-Enhanced Disease in the Cotton Rat Model Independently of the Presence of a Th1-Biasing (GLA-SE) or Th2-Biasing (Alum) Adjuvant | Q40349822 | ||
| A single, low dose of a cGMP recombinant BCG vaccine elicits protective T cell immunity against the human respiratory syncytial virus infection and prevents lung pathology in mice | Q40380870 | ||
| Virus-like particle vaccine by intranasal vaccination elicits protective immunity against respiratory syncytial viral infection in mice | Q40409972 | ||
| Non-invasive epicutaneous vaccine against Respiratory Syncytial Virus: Preclinical proof of concept. | Q40466188 | ||
| Differing manifestations of respiratory syncytial virus-associated severe lower respiratory tract infections in human immunodeficiency virus type 1-infected and uninfected children | Q40607262 | ||
| A Randomized, Blinded, Controlled, Dose-Ranging Study of a Respiratory Syncytial Virus Recombinant Fusion (F) Nanoparticle Vaccine in Healthy Women of Childbearing Age. | Q41060727 | ||
| The fusion glycoproteins of human respiratory syncytial virus of subgroups A and B: sequence conservation provides a structural basis for antigenic relatedness | Q43612954 | ||
| Recovery from infants with respiratory illness of a virus related to chimpanzee coryza agent (CCA). II. Epidemiologic aspects of infection in infants and young children. | Q45719599 | ||
| Low-Temperature-Grown RS Virus in Adult Volunteers | Q45810536 | ||
| Respiratory-syncytial-virus infections, reinfections and immunity. A prospective, longitudinal study in young children | Q45888997 | ||
| P304 | page(s) | 202-207 | |
| P577 | publication date | 2017-10-16 | |
| P1433 | published in | Current clinical microbiology reports | Q27725940 |
| P1476 | title | Respiratory Syncytial Virus Vaccine Approaches: a Current Overview | |
| P478 | volume | 4 |
Search more.